FdaApplication
ANDA 210332
Identifiers
- fda_app_no: ANDA210332
Properties
| Property | Value |
|---|---|
| applicant_name | FRESENIUS KABI USA LLC |
| application_type | ANDA |
| approval_date | 2022-03-28 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| DEXTROSE 5% AND LACTATED RINGER'S | CALCIUM CHLORIDE; DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE; SODIUM LACTATE | 20MG/100ML;5GM/100ML;30MG/100ML;600MG/100ML;310MG/100ML | INJECTABLE;INJECTION |
1 product